SPHERA FUNDS MANAGEMENT LTD. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 58 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 63.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$560,000
-62.9%
205,000
-54.4%
0.06%
-65.0%
Q1 2015$1,508,000450,0000.16%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
AMUSSEN HUNSAKER ASSOCIATES LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders